Tumor neoantigens: from basic research to clinical applications
T Jiang, T Shi, H Zhang, J Hu, Y Song, J Wei… - Journal of hematology & …, 2019 - Springer
Tumor neoantigen is the truly foreign protein and entirely absent from normal human
organs/tissues. It could be specifically recognized by neoantigen-specific T cell receptors …
organs/tissues. It could be specifically recognized by neoantigen-specific T cell receptors …
PD-1 and PD-L1 antibodies in cancer: current status and future directions
AV Balar, JS Weber - Cancer Immunology, Immunotherapy, 2017 - Springer
Immunotherapy has moved to the center stage of cancer treatment with the recent success of
trials in solid tumors with PD-1/PD-L1 axis blockade. Programmed death-1 or PD-1 is a …
trials in solid tumors with PD-1/PD-L1 axis blockade. Programmed death-1 or PD-1 is a …
[HTML][HTML] Proteogenomic characterization of endometrial carcinoma
We undertook a comprehensive proteogenomic characterization of 95 prospectively
collected endometrial carcinomas, comprising 83 endometrioid and 12 serous tumors. This …
collected endometrial carcinomas, comprising 83 endometrioid and 12 serous tumors. This …
Mutational signatures associated with tobacco smoking in human cancer
Tobacco smoking increases the risk of at least 17 classes of human cancer. We analyzed
somatic mutations and DNA methylation in 5243 cancers of types for which tobacco smoking …
somatic mutations and DNA methylation in 5243 cancers of types for which tobacco smoking …
UV signature mutations
DE Brash - Photochemistry and photobiology, 2015 - Wiley Online Library
Sequencing complete tumor genomes and exomes has sparked the cancer field's interest in
mutation signatures for identifying the tumor's carcinogen. This review and meta‐analysis …
mutation signatures for identifying the tumor's carcinogen. This review and meta‐analysis …
RNA-based diagnostic markers discovery and therapeutic targets development in cancer
H Wang, Q Meng, J Qian, M Li, C Gu, Y Yang - Pharmacology & …, 2022 - Elsevier
The present review aimed to outline different types of RNAs in cancer diagnostics and
treatment, and to provide novel insights into their clinical applications. RNAs, including …
treatment, and to provide novel insights into their clinical applications. RNAs, including …
E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis
Background E-cigarettes are currently being debated regarding their possible role in
smoking cessation and as they are becoming increasingly popular, the research to date …
smoking cessation and as they are becoming increasingly popular, the research to date …
Individualized medicine from prewomb to tomb
EJ Topol - Cell, 2014 - cell.com
That each of us is truly biologically unique, extending to even monozygotic," identical" twins,
is not fully appreciated. Now that it is possible to perform a comprehensive" omic" …
is not fully appreciated. Now that it is possible to perform a comprehensive" omic" …
TIGIT: a novel immunotherapy target moving from bench to bedside
BL Solomon, I Garrido-Laguna - Cancer Immunology, Immunotherapy, 2018 - Springer
Abstract Treatment strategies for patients with advanced solid tumors have traditionally been
based on three different paradigms: surgery, cytotoxics (chemotherapy or radiation therapy) …
based on three different paradigms: surgery, cytotoxics (chemotherapy or radiation therapy) …
Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia
Relapse of acute lymphoblastic leukemia (ALL) remains a leading cause of childhood
cancer-related death. Prior studies have shown clonal mutations at relapse often arise from …
cancer-related death. Prior studies have shown clonal mutations at relapse often arise from …